Search

Your search keyword '"Haber, He"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Haber, He" Remove constraint Author: "Haber, He"
94 results on '"Haber, He"'

Search Results

1. Review of Particle Physics*

2. Review of Particle Physics

3. Review of Particle Physics

4. Review of Particle Physics*

5. Review of particle physics

6. Review of particle physics

7. Physics interplay of the LHC and the ILC

8. Toward High Precision Higgs-Boson Measurements at the International Linear e+e- Collider

9. Review of particle physics

10. Review of Particle Physics

11. Review of Particle Physics: Particle data group

12. Report of the Higgs Working Group of the Tevatron Run 2 SUSY/Higgs Workshop

13. Review of Particle Physics

14. REVIEW OF PARTICLE PHYSICS (RPP2022)

15. Review of particle physics

16. REVIEW OF PARTICLE PHYSICS -- RPP2010

17. Review of Particle Physics (RPP2008)

18. Review of particle physics

20. Angiotensin II formation in human vasculature after chronic ACE inhibition: A prospective, randomized, placebo-controlled study

21. Review of Particle Properties

22. Review of Particle Physics

23. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.

24. Angiotensin II formation in human vasculature after chronic ACE inhibition: a prospective, randomized, placebo-controlled study. QUO VADIS Investigators.

25. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.

26. Influence of smoking status on progression of endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.

27. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.

28. Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals.

29. Activity of Procanbid, procainamide twice-daily formulation, to suppress ventricular premature depolarizations. The Study Group Investigators.

30. Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial.

31. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.

32. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.

Catalog

Books, media, physical & digital resources